OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it is collaborating with the Tuberous Sclerosis Alliance (TS Alliance) by sharing its data on genetic variants in an international database for the genetic disease tuberous sclerosis complex (TSC). Transgenomic offers genetic testing for the differential and definitive diagnosis of TSC. The company has agreed to provide anonymized information on genetic variants from its patient testing services to the TSC Variant Database, established to support advances in the understanding and treatment of the condition. Maintenance of this database, which is hosted at the Leiden University Medical Center and curated by researchers at University College London, is supported by the TS Alliance and the UK-based Tuberous Sclerosis Association.
Help employers find you! Check out all the jobs and post your resume.
